Managing Creativity in Organizations
ISBN:
9781403947680
Auflage:
2005
Verlag:
Palgrave Macmillan UK
Land des Verlags:
Vereinigtes Königreich
Erscheinungsdatum:
20.09.2005
Format:
Hardcover
Seitenanzahl:
256
Lieferung in 3-4 Werktagen
Versandkostenfrei ab 40 Euro in Österreich
Managing Creativity in Organizations addresses the notion of organizational creativity and innovation in general, and explores in some detail how it is achieved. The first part of the book critically reviews the literature on creativity. The second half explores the management of organizational creativity in the pharmaceutical industry. Here issues such as technology, cognition and leadership are introduced as central resources and practices in the management of organizational creativity and innovation. The research is based on management practices in four companies, all of whom have demonstrated a significant ability to exploit their organizational creativity.
Biografische Anmerkung
ALEXANDER STYHRE is Associate Professor at Chalmers University of Technology, Gothenburg, Sweden. He has published many papers on a variety of issues pertaining to the management of knowledge-intensive organizations and is the author of a number of books, including Management Writing out of Bounds (Copenhagen Business School Press, 2005), Collaborative Research in Organizations (co-edited, Sage, 2004), Understanding Knowledge Management (Copenhagen Business School Press, 2003) and Knowledge Sharing in Organizations (co-authored, Copenhagen Business School Press, 2003).
MATS SUNDGREN is a Scientific Adviser and Senior Informatics Scientist with AstraZeneca R&D, Mölndal, Sweden, and is affiliated with the Fenix Research Program at Chalmers University of Technology, Gothenburg, and the Stockholm School of Economics in Sweden. He has extensive experience in the pharmaceutical industry in new drug development, and has published in management journals on the topic of organizational creativity.
MATS SUNDGREN is a Scientific Adviser and Senior Informatics Scientist with AstraZeneca R&D, Mölndal, Sweden, and is affiliated with the Fenix Research Program at Chalmers University of Technology, Gothenburg, and the Stockholm School of Economics in Sweden. He has extensive experience in the pharmaceutical industry in new drug development, and has published in management journals on the topic of organizational creativity.
